TrialThe journal of prevention of Alzheimer's disease2019

Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms.

C Ballard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.